advanced search

ORAL DRUG DELIVERY173

Issue No #173  June 3rd, 2025


Download PDF


Issue 173 - May/Jun 2025

Inside the magazine

Interview: Patient Experience Versus Regulatory Compliance – Can Formulators Find a Middle Ground?
INTERVIEW
Dr Keat Theng Chow
Roquette
Interview: Patient Experience Versus Regulatory Compliance – Can Formulators Find a Middle Ground?
Dr Keat Theng Chow outlines the essential themes on Roquette’s radar regarding patient-centric drug design, upcoming regulatory changes and how drug producers can navigate both spheres to the benefit of all.
TPDs: DEVELOPING THE NEXT GENERATION OF ORAL THERAPEUTICS
GI/ORAL
Dr Anshul Gupte
PCI Pharma Services
TPDs: DEVELOPING THE NEXT GENERATION OF ORAL THERAPEUTICS
Dr Anshul Gupte looks at how targeted protein degraders are redefining the landscape of drug delivery, creating new strategies for previously untreatable diseases. The article goes on to consider the scientific, manufacturing and regulatory challenges ahead, while considering the role specialised CDMOs can play in overcoming these obstacles.
3D PRINTING: THE FUTURE OF PERSONALISED MEDICINES
GI/ORAL
Anna Kirstine Jørgensen
FabRx
3D PRINTING: THE FUTURE OF PERSONALISED MEDICINES
Anna Kirstine Jørgensen, Dr Abdul Basit along with Dr Alvaro Goyanes, discuss the role of 3D printing in shaping the future of personalised medication, and explain how FABRX’s two pharmaceutical 3D printers can help unlock its potential – extending even beyond Earth.
ENHANCING PERSONALISED MEDICINE: POWDOSE AND DIFFUCAPS FOR PRECISE ORAL SOLID DOSING
GI/ORAL
Thierry Jomini
AbbatiaLabs
ENHANCING PERSONALISED MEDICINE: POWDOSE AND DIFFUCAPS FOR PRECISE ORAL SOLID DOSING
Thierry Jomini, Stéphane Baronnet, Dr John van den Anker along with Giuseppe De Franza, evaluate the performance of the POWDOSE® system in delivering precise and repeatable doses of different formulations of Diffucaps®. The authors analyse the functionalities of combining Diffucaps with POWDOSE and highlighting its potential for improving personalised dosing regimens.
A STICKY ISSUE: TRANSFORMING OILY PLANT EXTRACTS INTO SOLID ORAL DOSAGE FORMS
EXPERT VIEW
Dr Maj-Britt Cepok
A STICKY ISSUE: TRANSFORMING OILY PLANT EXTRACTS INTO SOLID ORAL DOSAGE FORMS
Dr Maj-Britt Cepok discusses the increasing prevalence of plant extracts in the oral solid dosage market, considering how the common physical properties of these ingredients can both provide benefits and pose a challenge to formulators looking to capitalise on this rapidly growing market segment.
Top